KCM
SNY icon

Kathmere Capital Management’s Sanofi SNY Stock Holding History

Kathmere Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$253K Buy
5,250
+318
+6% +$14.8K 0.02% 516
2025
Q4 		$239K Buy
+4,932
New +$244K 0.02% 475
2025
Q3 		– Sell
-4,578
Closed -$221K – 549
2025
Q2 		$221K Sell
4,578
-47
-1% -$2.4K 0.02% 432
2025
Q1 		$257K Buy
+4,625
New +$250K 0.02% 359
2021
Q1 		– Sell
-500
Closed -$24K – 361
2020
Q4 		$24K Buy
+500
New +$24.7K 0.01% 278

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Kathmere Capital Management's SNY Position: Q1 2026 in Review

Kathmere Capital Management increased its Sanofi (SNY) stake by 6.4% in Q1 2026, buying an estimated $14.8K and bringing the position to 5,250 shares worth $253K. The position accounts for 0.02% of the portfolio, ranked #516.

Kathmere Capital Management first reported a position in SNY in Q4 2020 and has held it in 5 quarters since. The position peaked at $257K in Q1 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Kathmere Capital Management held 5,250 shares of Sanofi worth $253K as of Q1 2026.
  • Kathmere Capital Management bought 318 Sanofi shares in Q1 2026, an estimated $14.8K.
  • Sanofi made up 0.02% of Kathmere Capital Management's portfolio in Q1 2026, its #516 holding.
  • Kathmere Capital Management first reported a position in Sanofi in Q4 2020 and has held it in 5 quarters since.
  • Kathmere Capital Management's Sanofi position peaked at $257K in Q1 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Kathmere Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.